Hemispherx BioPharma Inc. (HEB) Fell -8.32% or -0.03 To Price $0.31 On Wednesday


Hemispherx BioPharma Inc. (HEB) fell -8.32% or -0.03 to $0.31. It is approximately 370370 shares traded, which is 43.81% compare to the average total volume 845422. The market cap of HEB is $14.15 million. The year to date change is -835.26%. The 52 week price range is from $0.28 to $0.74. Price of HEB have changed 11.18% during last week. It have changed 4.50% over last month, -32.51% over last 3 months, 3.34% over last 6 months and -35.13% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for HEB is 0.35. It is 12.90% above current price. The 200-day Moving Averages for HEB is 0.38. It is 22.58% above current price. The 52-week High is 0.74. It is 138.71% from the current price. The 52-week Low is 0.28. It is -9.68% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of HEB is 0.76 on 2018-05-15. Short % to float is 1.50%. There are some statistics of HEB. It is has market cap $14.15 million. The share outstanding is 46.20 million. The average volume is 845422. The percent of top 15 Institution holding is 3.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of HEB is -64.73%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of HEB is -45.57%.


Tags:

Share this post